Red bone marrow residence time data based on the plasma method were taken from Makris et al. [5], and the S RM←RM, S RM←RB and reference man/woman RM volume values used in the calculation of (self and total) RM absorbed dose were taken from OLINDA/EXM 1.1.
In the group receiving autologous marrow the time for recovery of peripheral-blood granulocytes to 800/mm2 or greater was significantly less (P = 0.01) than in those not receiving marrow.
Because the majority of patients with AML will achieve complete remission with induction chemotherapy, collection and complete diagnostic and prognostic testing of the bone marrow at time of diagnosis is critical to predicting outcomes and determining post-induction treatment strategies.
Other outcomes evaluated included the following: the number of tests performed, repeat bone marrow studies, time to final diagnosis, changes in chemotherapy in the 60-days post-biopsy, and testing costs and all-cause health care costs in the 1-year and 11-months remaining in the follow-up period.
Close matching of tissue between donor and recipient is also essential to minimize GVHD, with autologous transplantation being the best method to avoid the disease (the patients donate their own marrow at times of remission to be used later).
This provides information on the general anatomy of the joint, for example, identifying abnormalities in the menisci, cruciate ligaments, or other joint components and the subchondral bone outline and underlying marrow signal (repetition time [TR] = 722 ms; echo time [TE] = 20 ms; field of view = 20 cm; slice thickness = 3/0.3 mm; matrix 512 × 336; acquisition = 2).
All patients had > 20% blasts in the bone marrow at the time of first AML diagnosis, as required by the WHO criteria; at the time of inclusion, three of the relapse patients had < 20% of blasts in the marrow, but for the patients included at the time of diagnosis the median blast count was 50% (range 20 to 95%) and the counts did not differ between responders and nonresponders.
Ms. Nappier regained her health after the transplant but a few years ago, she was told she had acute leukemia and received a second bone marrow transplant, this time from Donna.
Thus, high metabolic activity of proliferating cells in bone marrow requires longer time for [18F]-FDG to reach steady state in this tissue even under physiological conditions.
In this study, we attempted to augment recipient chimerism by the transfer of donor bone marrow at the time of rat laryngeal transplant.
